TScan Therapeutics Q1 2026 Earnings Narrowing Loss Despite EPS Miss Stock Gains on Pipeline Progress BUSEP Q1 2026 Earnings 132 EPS Surprise Boosted by Solid Core Operations PDPA Q4 2025 Earnings EPS Slightly Below Estimates Preferred Stock Unchanged MELI Q1 2026 Earnings EPS Miss Despite Strong Operational Momentum HGTY Q1 2026 Earnings EPS Slightly Beats Estimate as Company Navigates Growth Investments MacroGenics MGNX Q1 2026 Earnings Narrowing Loss on EPS Surprise as Stock Rebounds